KDM4B
Lysine-specific demethylase 4B
Also known as: JMJD2B, KDM4B_HUMAN, KIAA0876, TDRD14B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O94953
- Gene
- KDM4B
- Ensembl
- ENSG00000127663
- Chromosome
- 19
- Canonical length
- 1096 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Enables histone H3K36 demethylase activity and histone H3K9me2/H3K9me3 demethylase activity. Predicted to be involved in brain development; chromatin remodeling; and regulation of gene expression. Located in cytosol and nucleoplasm. Implicated in autosomal dominant intellectual developmental disorder 65; breast cancer; colorectal cancer; malignant peripheral nerve sheath tumor; and stomach cancer. Biomarker of several diseases, including alopecia areata; lung cancer; medulloblastoma; prostate cancer; and stomach cancer. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1096 residues, UniProt reviewed canonical sequence.
>O94953|KDM4B
1 MGSEDHGAQN PSCKIMTFRP TMEEFKDFNK YVAYIESQGA HRAGLAKIIP PKEWKPRQTY
61 DDIDDVVIPA PIQQVVTGQS GLFTQYNIQK KAMTVGEYRR LANSEKYCTP RHQDFDDLER
121 KYWKNLTFVS PIYGADISGS LYDDDVAQWN IGSLRTILDM VERECGTIIE GVNTPYLYFG
181 MWKTTFAWHT EDMDLYSINY LHFGEPKSWY AIPPEHGKRL ERLAIGFFPG SSQGCDAFLR
241 HKMTLISPII LKKYGIPFSR ITQEAGEFMI TFPYGYHAGF NHGFNCAEST NFATLRWIDY
301 GKVATQCTCR KDMVKISMDV FVRILQPERY ELWKQGKDLT VLDHTRPTAL TSPELSSWSA
361 SRASLKAKLL RRSHRKRSQP KKPKPEDPKF PGEGTAGAAL LEEAGGSVKE EAGPEVDPEE
421 EEEEPQPLPH GREAEGAEED GRGKLRPTKA KSERKKKSFG LLPPQLPPPP AHFPSEEALW
481 LPSPLEPPVL GPGPAAMEES PLPAPLNVVP PEVPSEELEA KPRPIIPMLY VVPRPGKAAF
541 NQEHVSCQQA FEHFAQKGPT WKEPVSPMEL TGPEDGAASS GAGRMETKAR AGEGQAPSTF
601 SKLKMEIKKS RRHPLGRPPT RSPLSVVKQE ASSDEEASPF SGEEDVSDPD ALRPLLSLQW
661 KNRAASFQAE RKFNAAAART EPYCAICTLF YPYCQALQTE KEAPIASLGK GCPATLPSKS
721 RQKTRPLIPE MCFTSGGENT EPLPANSYIG DDGTSPLIAC GKCCLQVHAS CYGIRPELVN
781 EGWTCSRCAA HAWTAECCLC NLRGGALQMT TDRRWIHVIC AIAVPEARFL NVIERHPVDI
841 SAIPEQRWKL KCVYCRKRMK KVSGACIQCS YEHCSTSFHV TCAHAAGVLM EPDDWPYVVS
901 ITCLKHKSGG HAVQLLRAVS LGQVVITKNR NGLYYRCRVI GAASQTCYEV NFDDGSYSDN
961 LYPESITSRD CVQLGPPSEG ELVELRWTDG NLYKAKFISS VTSHIYQVEF EDGSQLTVKR
1021 GDIFTLEEEL PKRVRSRLSL STGAPQEPAF SGEEAKAAKR PRVGTPLATE DSGRSQDYVA
1081 FVESLLQVQG RPGAPFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KDM4B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 31 nTPM
- thyroid gland: 28 nTPM
- cerebellum: 24 nTPM
- prostate: 24 nTPM
- spleen: 21 nTPM
- cervix: 21 nTPM
Single-cell type
- neutrophils: 748 nCPM
- rod photoreceptor cells: 300 nCPM
- cone photoreceptor cells: 253 nCPM
- retinal horizontal cells: 236 nCPM
- prostatic glandular cells: 222 nCPM
- retinal amacrine cells: 221 nCPM
Immune cell
- naive B-cell: 5.1 nTPM
- neutrophil: 4.6 nTPM
- memory B-cell: 4.2 nTPM
- eosinophil: 1.9 nTPM
- plasmacytoid DC: 1.7 nTPM
- basophil: 1.5 nTPM
Brain region
- cerebellum: 51 nTPM
- white matter: 43 nTPM
- cerebral cortex: 42 nTPM
- medulla oblongata: 39 nTPM
- hippocampal formation: 38 nTPM
- thalamus: 37 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KDM4B.
Disease | AllUniProt
Conditions KDM4B is implicated in, by any mechanism.
- Intellectual developmental disorder, autosomal dominant 65 (MRD65) MIM:619320
Disease | GeneticClinVar
37 pathogenic / likely-pathogenic of 437 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual developmental disorder, autosomal dominant 65
- Inborn genetic diseases
- Neurodevelopmental delay
- Neurodevelopmental disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.17
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.48
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- histone demethylase activity
- histone H3K36 demethylase activity
- histone H3K9 demethylase activity
- histone H3K9me2/H3K9me3 demethylase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, PHD-type
- Tudor domain
- JmjC domain
- JmjN domain
- Zinc finger, FYVE/PHD-type
- Zinc finger, RING/FYVE/PHD-type
- Zinc finger, PHD-finger
- Extended PHD (ePHD) domain
- Lysine-specific demethylase 4-like, Tudor domain
- JmjC domain, hydroxylase
- jmjN domain
- PHD-finger
- PHD-zinc-finger like domain
- Jumonji domain-containing protein 2A Tudor domain
- Lysine-specific demethylase 4B, first Tudor domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KDM4B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KDM4B as an antibody target. Whether an autoantibody or antibody against KDM4B could matter depends on whether native KDM4B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KDM4B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KDM4B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...